It has been reported that enhanced activity of NHE-1 increases intracellular Na+ with a consequent rise in Ca2+ through the Na+/Ca2+ exchanger, leading to cardiac dysfunction, cardiac hypertrophy and heart failure (Cingolani and Ennis, 2007). The gene discussed is SLC9A1; the disease is cardiac hypertrophy.